Chan Henry Lee's most recent trade in BeiGene Ltd - ADR was a trade of 3,458 Share Option (Right to Buy) done . Disclosure was reported to the exchange on July 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2026 | 3,458 | 79,768 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2026 | 2,626 | 17,238 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2026 | 2,548 | 105,300 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 302.46 per share. | 08 Jul 2026 | 664 | 0 (0%) | 0% | 302.5 | 200,833 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 213.32 per share. | 08 Jul 2026 | 266 | 468 (0%) | 0% | 213.3 | 56,743 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 194.47 per share. | 08 Jul 2026 | 202 | 202 (0%) | 0% | 194.5 | 39,283 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.03 per share. | 08 Jul 2026 | 196 | 664 (0%) | 0% | 159.0 | 31,170 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 265.97 per share. | 16 Jun 2026 | 590 | 0 (0%) | 0% | 266.0 | 156,925 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2026 | 87,308 | 87,308 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2026 | 45,071 | 346,554 (0%) | 0% | 0 | Ordinary Shares | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 257.64 per share. | 11 Jun 2026 | 428 | 0 (0%) | 0% | 257.6 | 110,268 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 270.24 per share. | 08 Jun 2026 | 711 | 160 (0%) | 0% | 270.2 | 192,138 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 271.26 per share. | 08 Jun 2026 | 160 | 0 (0%) | 0% | 271.3 | 43,401 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2026 | 1,729 | 83,226 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2026 | 1,313 | 19,864 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2026 | 1,274 | 107,848 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 310.72 per share. | 13 May 2026 | 332 | 0 (0%) | 0% | 310.7 | 103,159 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 213.32 per share. | 13 May 2026 | 133 | 234 (0%) | 0% | 213.3 | 28,372 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 194.47 per share. | 13 May 2026 | 101 | 101 (0%) | 0% | 194.5 | 19,641 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.03 per share. | 13 May 2026 | 98 | 332 (0%) | 0% | 159.0 | 15,585 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2026 | 1,729 | 84,955 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2026 | 1,313 | 21,177 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2026 | 1,274 | 109,122 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 311.59 per share. | 08 Apr 2026 | 332 | 0 (0%) | 0% | 311.6 | 103,448 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 213.32 per share. | 08 Apr 2026 | 133 | 234 (0%) | 0% | 213.3 | 28,372 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 194.47 per share. | 08 Apr 2026 | 101 | 101 (0%) | 0% | 194.5 | 19,641 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.03 per share. | 08 Apr 2026 | 98 | 332 (0%) | 0% | 159.0 | 15,585 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2026 | 1,729 | 86,684 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2026 | 1,430 | 22,490 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2026 | 1,274 | 110,396 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 300.00 per share. | 11 Mar 2026 | 341 | 0 (0%) | 0% | 300 | 102,300 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 213.32 per share. | 11 Mar 2026 | 133 | 243 (0%) | 0% | 213.3 | 28,372 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 194.47 per share. | 11 Mar 2026 | 110 | 110 (0%) | 0% | 194.5 | 21,392 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.03 per share. | 11 Mar 2026 | 98 | 341 (0%) | 0% | 159.0 | 15,585 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2026 | 65,390 | 288,496 (0%) | 0% | 0 | Ordinary Shares | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2026 | 29,874 | 318,370 (0%) | 0% | 0 | Ordinary Shares | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2026 | 8,606 | 88,413 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2026 | 6,526 | 23,920 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2026 | 6,448 | 111,670 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 350.00 per share. | 04 Feb 2026 | 996 | 0 (0%) | 0% | 350 | 348,600 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 348.79 per share. | 04 Feb 2026 | 664 | 996 (0%) | 0% | 348.8 | 231,597 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 213.32 per share. | 04 Feb 2026 | 662 | 1,164 (0%) | 0% | 213.3 | 141,218 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 194.47 per share. | 04 Feb 2026 | 502 | 502 (0%) | 0% | 194.5 | 97,624 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.03 per share. | 04 Feb 2026 | 496 | 1,660 (0%) | 0% | 159.0 | 78,879 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 3,458 | 97,019 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 2,626 | 30,446 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 2,548 | 118,118 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 331.76 per share. | 07 Jan 2026 | 664 | 0 (0%) | 0% | 331.8 | 220,289 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 213.32 per share. | 07 Jan 2026 | 266 | 468 (0%) | 0% | 213.3 | 56,743 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 194.47 per share. | 07 Jan 2026 | 202 | 202 (0%) | 0% | 194.5 | 39,283 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.03 per share. | 07 Jan 2026 | 196 | 664 (0%) | 0% | 159.0 | 31,170 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2025 | 1,729 | 102,206 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2025 | 1,729 | 100,477 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2025 | 1,313 | 34,385 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2025 | 1,313 | 33,072 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2025 | 1,274 | 121,940 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2025 | 1,274 | 120,666 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 325.00 per share. | 10 Dec 2025 | 332 | 0 (0%) | 0% | 325 | 107,900 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 318.28 per share. | 10 Dec 2025 | 332 | 0 (0%) | 0% | 318.3 | 105,669 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 213.32 per share. | 10 Dec 2025 | 133 | 234 (0%) | 0% | 213.3 | 28,372 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 213.32 per share. | 10 Dec 2025 | 133 | 234 (0%) | 0% | 213.3 | 28,372 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 194.47 per share. | 10 Dec 2025 | 101 | 101 (0%) | 0% | 194.5 | 19,641 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 194.47 per share. | 10 Dec 2025 | 101 | 101 (0%) | 0% | 194.5 | 19,641 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.03 per share. | 10 Dec 2025 | 98 | 332 (0%) | 0% | 159.0 | 15,585 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.03 per share. | 10 Dec 2025 | 98 | 332 (0%) | 0% | 159.0 | 15,585 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 5,174 | 103,935 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 3,926 | 35,698 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 3,848 | 123,214 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 348.75 per share. | 12 Nov 2025 | 664 | 332 (0%) | 0% | 348.8 | 231,570 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 213.32 per share. | 12 Nov 2025 | 398 | 700 (0%) | 0% | 213.3 | 84,901 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 350.00 per share. | 12 Nov 2025 | 332 | 0 (0%) | 0% | 350 | 116,200 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 194.47 per share. | 12 Nov 2025 | 302 | 302 (0%) | 0% | 194.5 | 58,730 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.03 per share. | 12 Nov 2025 | 296 | 996 (0%) | 0% | 159.0 | 47,073 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2025 | 116,493 | 109,109 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 213.32 per share. | 08 Oct 2025 | 8,961 | 9,263 (0%) | 0% | 213.3 | 1,911,561 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 350.22 per share. | 08 Oct 2025 | 4,733 | 4,162 (0%) | 0% | 350.2 | 1,657,580 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 351.12 per share. | 08 Oct 2025 | 4,162 | 0 (0%) | 0% | 351.1 | 1,461,375 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2025 | 3,926 | 39,624 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2025 | 3,848 | 127,062 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 350.00 per share. | 08 Oct 2025 | 1,112 | 0 (0%) | 0% | 350 | 389,200 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 347.82 per share. | 08 Oct 2025 | 664 | 8,895 (0%) | 0% | 347.8 | 230,952 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 194.47 per share. | 08 Oct 2025 | 302 | 302 (0%) | 0% | 194.5 | 58,730 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.03 per share. | 08 Oct 2025 | 296 | 9,559 (0%) | 0% | 159.0 | 47,073 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2025 | 88,426 | 43,550 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2025 | 23,348 | 225,602 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 194.47 per share. | 10 Sep 2025 | 6,802 | 6,802 (0%) | 0% | 194.5 | 1,322,785 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 325.19 per share. | 10 Sep 2025 | 4,776 | 4,118 (0%) | 0% | 325.2 | 1,553,124 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2025 | 3,848 | 130,910 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 325.73 per share. | 10 Sep 2025 | 3,318 | 800 (0%) | 0% | 325.7 | 1,080,760 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 213.32 per share. | 10 Sep 2025 | 1,796 | 8,598 (0%) | 0% | 213.3 | 383,123 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 325.00 per share. | 10 Sep 2025 | 1,112 | 0 (0%) | 0% | 325 | 361,400 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 327.93 per share. | 10 Sep 2025 | 500 | 0 (0%) | 0% | 327.9 | 163,965 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 326.80 per share. | 10 Sep 2025 | 300 | 500 (0%) | 0% | 326.8 | 98,040 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.03 per share. | 10 Sep 2025 | 296 | 8,894 (0%) | 0% | 159.0 | 47,073 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2025 | 56,953 | 131,976 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2025 | 50,037 | 134,758 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 300.19 per share. | 13 Aug 2025 | 6,052 | 2,178 (0%) | 0% | 300.2 | 1,816,724 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 194.47 per share. | 13 Aug 2025 | 4,381 | 4,381 (0%) | 0% | 194.5 | 851,973 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 301.00 per share. | 13 Aug 2025 | 3,849 | 0 (0%) | 0% | 301.0 | 1,158,553 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.03 per share. | 13 Aug 2025 | 3,849 | 8,230 (0%) | 0% | 159.0 | 612,106 | American Depositary Shares |
| BeiGene Ltd (ADR) | Chan Henry Lee | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 300.00 per share. | 13 Aug 2025 | 1,112 | 0 (0%) | 0% | 300 | 333,600 | American Depositary Shares |